ZYMAR
Google image searchProduct monograph
Active ingredient
gatifloxacin, 0.3 %/W/V
DIN: 02257270
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 06-DEC-2023
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01A — ANTIINFECTIVES (ATC, ATC/DDD)
- S01AE — Fluoroquinolones (ATC, ATC/DDD)
- S01AE06 — GATIFLOXACIN (ATC/DDD)
Reference brand drug: Zymar
Pharmaceutical standard: MFR
